Senti Biosciences is trading $0.29 (-8.17%) amid broad risk-off sentiment as oil exceeds $100 amid escalating U.S.-Iran tensions.

  • No clearly reported company-specific announcement on September 9, 2026 explains the decline.
  • Recent financing disclosures included $2.0 million in senior secured convertible notes and a conditional $2.5 million equity commitment; these are prior developments, not confirmed same-day catalysts.
  • Major U.S. indexes are down more than 0.5%, reinforcing broader risk-off pressure.